Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Share-based Compensation (2009 - 2026)

Updated

Protagenic Therapeutics, Inc.new (PTIX) reported Share-based Compensation of $62,409 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 41.1% from $105,868 a year earlier and down 6.9% from the prior quarter.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Share-based Compensation (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Protagenic Therapeutics, Inc.new's Share-based Compensation came in at $317,015, down 55.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $418,589.

  • Share-based Compensation has a five-year compound annual growth rate of -22.7% (FY2021 to FY2026).
  • By fiscal year, Share-based Compensation came in at $923,139 in FY2024 (+38.4%), $666,828 in FY2023 (-22.9%) and $864,681 in FY2022 (-43.1%).
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Share-based Compensation since fiscal Q3 2015.
  • Year over year, Share-based Compensation has now declined in each of the last three quarters.
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $67,012 (Q1 2027), $91,652 (Q4 2026) and $95,942 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,305.71 Bn 1,279.33 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 694.23 Bn 614.09 Bn 17.30 Bn 357.00 Mn
3 AbbVie 528.96 Bn 496.97 Bn 13.12 Bn 160.00 Mn
4 Merck 365.92 Bn 328.86 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 314.95 Bn 288.19 Bn - -
6 Astrazeneca 289.15 Bn 262.67 Bn 13.26 Bn -
7 Amgen 254.11 Bn 205.76 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 211.85 Bn 186.96 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.73 Bn 113.09 Bn 12.56 Bn 362.00 Mn
10 Protagenic Therapeutics, Inc.new 850,797.76 -3.51 Mn - 62,409.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 62,409.00
Jun 30, 2026 67,012.00
Mar 31, 2026 91,652.00
Dec 31, 2025 95,942.00
Sep 30, 2025 105,868.00
Jun 30, 2025 125,127.00
Mar 31, 2025 236,014.00
Dec 31, 2024 245,436.00
Sep 30, 2024 250,403.00
Jun 30, 2024 265,439.00
Mar 31, 2024 161,861.00
Dec 31, 2023 166,707.00
Sep 30, 2023 166,707.00
Jun 30, 2023 166,707.00
Mar 31, 2023 166,707.00
Dec 31, 2022 198,688.00
Sep 30, 2022 214,679.00
Jun 30, 2022 215,535.00
Mar 31, 2022 235,779.00
Dec 31, 2021 218,166.00
API Access

Protagenic Therapeutics, Inc.new Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PTIX&period=max&api_key=YOUR_API_KEY